How CME Group’s Cross‑Margining, SOFR Benchmark, and New Dividend Futures Drive Capital Efficiency and Market Growth
Discover how CME Group’s new cross‑margining, ESMA benchmark approval, and dividend‑futures launch boost capital efficiency and product choice—while staying alert to NYMEX’s market‑integrity probe.
3 minutes to read









